• Author: Helen Ma
Clear all

Cancer risk in Veterans enlisted in the United States military after September 11, 2001: A retrospective cohort study

Abstract: INTRODUCTION: Potential exposures to toxicants during military deployment may increase the risk of developing cancer. This study was undertaken to determine whether there …

Middle East deployment and lymphoid malignancies in US Veterans: A matched case-control analysis

Abstract: Background/Objective: US military personnel deployed to the Middle East were potentially subjected to harmful exposures, such as carcinogens from burn pits, which may …

Clinical information extraction from notes of Veterans with lymphoid malignancies: Natural language processing study

Abstract: BACKGROUND: Clinical natural language processing (cNLP) techniques are commonly developed and used to extract information from clinical notes to facilitate clinical …

Polygenic risk, Agent Orange exposure, and lymphoid neoplasms in the Veterans Affairs Million Veteran Program

Abstract: Importance: Agent Orange (AO), a toxic herbicide mixture contaminated with carcinogenic dioxin, was widely used during the Vietnam War. Although epidemiologic evidence …

Treatment and survival of U.S. Vietnam Veterans with concurrent lymphoid malignancies

Abstract: INTRODUCTION: In Vietnam veterans, exposure to military toxicants, such as Agent Orange, may be associated with lymphoid malignancies. Toxicant exposure may increase the …

A retrospective analysis of factors impacting survival in United States military Veterans with multiple myeloma

Abstract: This study investigates the long-term outcomes and causes of death in multiple myeloma (MM) patients treated in the Veterans Health Administration (VHA), with a focus on …

Survival in Agent Orange exposed and unexposed Vietnam era Veterans who were diagnosed with lymphoid malignancies

Abstract: Agent Orange (AO) was an herbicide mixture that was contaminated with the carcinogenic 2,3,7,8-tetrachlorodibenzo-p-dioxin. . Between 1962 and 1971, AO was widely sprayed …

Treatment patterns and outcomes in U.S. Military Veterans diagnosed with chronic lymphocytic leukemia (CLL)

Abstract: INTRODUCTION: U.S. veterans in the Veterans Affairs (VA) Healthcare System are managed in a national single-payer system with access to FDA-approved therapies. …

An analysis of veterans diagnosed with large granular lymphocytic disorders at the national Veteran Affairs Healthcare System

Abstract: This is a retrospective, secondary analysis of electronic health records of a VA cohort of patients diagnosed with LGL leukemia from January 1, 1998 to December 31, 2020 …